Adele M. Gulfo insider trades

Open-market stock purchases and sales by Adele M. Gulfo, Director at Enpro Inc, from SEC Form 4 filings since May 5, 2016.

Recent trades

DateStockTradeValue
Jun 17, 2026NPO Enpro IncBought (not open market)$1.5K
Jun 17, 2026NPO Enpro IncBought (not open market)$165
May 28, 2026TYRA Tyra Biosciences, IncBought (not open market)—
Mar 18, 2026NPO Enpro IncBought (not open market)$1.3K
Mar 18, 2026NPO Enpro IncBought (not open market)$164
Feb 12, 2026NPO Enpro IncBought (not open market)$140K
Jan 7, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Jan 7, 2026NAMS NewAmsterdam Pharma Co NVBought (not open market)—
Dec 31, 2025NPO Enpro IncBought (not open market)$25K
Dec 17, 2025NPO Enpro IncBought (not open market)$1.2K
Dec 17, 2025NPO Enpro IncBought (not open market)$123

Companies traded

  • NPO Enpro Inc: 1 buy, last Jun 17, 2026
  • TYRA Tyra Biosciences, Inc: other filings, last May 28, 2026
  • NAMS NewAmsterdam Pharma Co NV: other filings, last Jan 7, 2026
  • MYOV Myovant Sciences Ltd: other filings, last Mar 10, 2023
  • BMS Bemis Co Inc: other filings, last Jun 11, 2019

Get free alerts when Adele M. Gulfo files a new trade →